Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
Newsroom
Press Releases

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Careers
Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

August 2023

08.14.2023
- Prescription Medicines
Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
08.01.2023
Pfizer Reports Second-Quarter 2023 Results

July 2023

07.27.2023
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
07.21.2023
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
07.19.2023
Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate

June 2023

06.28.2023
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
06.27.2023
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
06.26.2023
- Research and Pipeline
- Research
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
06.23.2023
- Prescription Medicines
- Medicines
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
06.22.2023
- Financial
- Finance
Pfizer Declares Third-Quarter 2023 Dividend
06.20.2023
- Prescription Medicines
- Medicines
Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval
06.20.2023
- Financial
- Finance
Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with Analysts

Page 9
Page 10
Current page 11
Page 12
Page 13

Investors
Media
Careers
Partners

Grant Seekers
Healthcare Professionals
Business to Business
Merchandise

Privacy Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube